19-42333679-G-A

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BS1_Supporting

The NM_001271938.2(MEGF8):​c.262G>A​(p.Val88Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000446 in 1,613,864 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000027 ( 0 hom. )

Consequence

MEGF8
NM_001271938.2 missense

Scores

7
9
3

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 4.83

Publications

0 publications found
Variant links:
Genes affected
MEGF8 (HGNC:3233): (multiple EGF like domains 8) The protein encoded by this gene is a single-pass type I membrane protein of unknown function that contains several EGF-like domains, Kelch repeats, and PSI domains. Defects in this gene are a cause of Carpenter syndrome 2. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
MEGF8 Gene-Disease associations (from GenCC):
  • MEGF8-related Carpenter syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, G2P, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • Carpenter syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000217 (33/152208) while in subpopulation AFR AF = 0.000676 (28/41438). AF 95% confidence interval is 0.000479. There are 0 homozygotes in GnomAd4. There are 13 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MEGF8NM_001271938.2 linkc.262G>A p.Val88Met missense_variant Exon 2 of 42 ENST00000251268.11 NP_001258867.1 Q7Z7M0-1
MEGF8NM_001410.3 linkc.262G>A p.Val88Met missense_variant Exon 2 of 41 NP_001401.2 Q7Z7M0-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MEGF8ENST00000251268.11 linkc.262G>A p.Val88Met missense_variant Exon 2 of 42 5 NM_001271938.2 ENSP00000251268.5 Q7Z7M0-1
MEGF8ENST00000334370.8 linkc.262G>A p.Val88Met missense_variant Exon 2 of 41 1 ENSP00000334219.4 Q7Z7M0-2
MEGF8ENST00000378073.5 linkc.-6824G>A 5_prime_UTR_premature_start_codon_gain_variant Exon 2 of 41 5 ENSP00000367313.4 F5GZG7
MEGF8ENST00000378073.5 linkc.-6824G>A 5_prime_UTR_variant Exon 2 of 41 5 ENSP00000367313.4 F5GZG7

Frequencies

GnomAD3 genomes
AF:
0.000217
AC:
33
AN:
152208
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000676
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000722
AC:
18
AN:
249172
AF XY:
0.0000444
show subpopulations
Gnomad AFR exome
AF:
0.000581
Gnomad AMR exome
AF:
0.0000869
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000177
Gnomad OTH exome
AF:
0.000330
GnomAD4 exome
AF:
0.0000267
AC:
39
AN:
1461656
Hom.:
0
Cov.:
31
AF XY:
0.0000234
AC XY:
17
AN XY:
727116
show subpopulations
African (AFR)
AF:
0.000508
AC:
17
AN:
33480
American (AMR)
AF:
0.000134
AC:
6
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53358
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000540
AC:
6
AN:
1111862
Other (OTH)
AF:
0.0000994
AC:
6
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000217
AC:
33
AN:
152208
Hom.:
0
Cov.:
32
AF XY:
0.000175
AC XY:
13
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.000676
AC:
28
AN:
41438
American (AMR)
AF:
0.000262
AC:
4
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68042
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000306
Hom.:
0
Bravo
AF:
0.000223
ESP6500AA
AF:
0.000483
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000991
AC:
12
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

MEGF8-related Carpenter syndrome Uncertain:1
Jul 01, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces valine with methionine at codon 88 of the MEGF8 protein (p.Val88Met). The valine residue is weakly conserved and there is a small physicochemical difference between valine and methionine. This variant is present in population databases (rs372955721, ExAC 0.08%). This variant has not been reported in the literature in individuals with MEGF8-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Uncertain:1
Feb 19, 2024
Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PM3_Supporting, PP2, PP3 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.86
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Uncertain
-0.080
CADD
Pathogenic
29
DANN
Uncertain
1.0
DEOGEN2
Benign
0.27
.;T
Eigen
Pathogenic
0.79
Eigen_PC
Pathogenic
0.69
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.93
D;D
M_CAP
Pathogenic
0.36
D
MetaRNN
Uncertain
0.57
D;D
MetaSVM
Uncertain
0.44
D
MutationAssessor
Pathogenic
3.4
M;M
PhyloP100
4.8
PrimateAI
Pathogenic
0.84
D
PROVEAN
Uncertain
-2.4
N;N
REVEL
Uncertain
0.46
Sift
Uncertain
0.0030
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
D;.
Vest4
0.66
MVP
0.80
MPC
1.2
ClinPred
0.30
T
GERP RS
5.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.23
gMVP
0.54
Mutation Taster
=59/41
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs372955721; hg19: chr19-42837831; COSMIC: COSV52074222; API